Please login to the form below

Not currently logged in
Email:
Password:

Ogilvy & Mather and CommonHealth to merge

Two of WPP's healthcare marketing networks, Ogilvy & Mather and CommonHealth are to merge to form Ogilvy CommonHealth Worldwide

Two of WPP's healthcare marketing networks, Ogilvy & Mather and CommonHealth are to merge to form Ogilvy CommonHealth Worldwide.

The new group will have more than 1,100 employees in 33 countries. Its offerings will include professional and consumer advertising and promotion, relationship marketing, digital/interactive services, media planning and buying, public affairs and relations, managed care marketing, medical education, clinical trial recruitment, market research and analytics and strategic consulting.

CommonHealth's president and CEO Matt Giegerich will become chairman and CEO of the new organisation. He said: "By combining our two organisations – and the remarkable collective talent pool within – we can offer clients all the communications resources necessary to create and grow powerful, unified global brands in a rapidly evolving healthcare environment."

The group will operate under the Ogilvy CommonHealth Worldwide umbrella, but maintain individual Ogilvy CommonHealth and Ogilvy Healthworld brand identities in some markets. An executive council, comprised of leadership from both organisations, will oversee daily operations.

28th June 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics